SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2

10.3389/fimmu.2022.854952

Saved in:

Bibliographic Details
Main Authors:	Wang, R, Zhang, Q, Zhang, R, Aw, ZQ, Chen, P, Wong, YH, Hong, J, Ju, B, Shi, X, Ding, Q, Zhang, Z, Chu, JJH, Zhang, L
Other Authors:	DEPT OF MICROBIOLOGY & IMMUNOLOGY
Format:	Article
Published:	Frontiers Media SA 2022
Subjects:	ACE2 orthologues Omicron variant SARS-CoV-2 infection (COVID-19) antibody neutralization plasma neutralization Angiotensin-Converting Enzyme 2 Animals Animals, Wild Antibodies, Monoclonal Antibodies, Neutralizing COVID-19 Immunization, Passive Mice SARS-CoV-2
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235420
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
by: Shan, Sisi, et al.
Published: (2022)

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
by: Low, Jenny G., et al.
Published: (2023)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
by: Meng, Bo, et al.
Published: (2022)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium.
by: Peng, Yang, et al.
Published: (2023)

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
by: Tan, TT, et al.
Published: (2023)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023)

Laboratory practice in the face of Covid-19
by: Lau, C.S., et al.
Published: (2021)

The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan
by: Liu, LT, et al.
Published: (2023)

CHARACTERIZATION OF VIRAL-VIRAL AND VIRAL HOST INTERACTIONS THAT CONTRIBUTE TO THE REPLICATION AND PATHOGENESIS OF THE SEVERE ACUTE RESPIRATORY SYNDROME VIRUS (SARS-COV)
by: KENG CHOONG TAT
Published: (2011)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
by: Zakir, Tasnim Saifudin, et al.
Published: (2022)

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti?COVID?19 Therapeutics
by: Teodori, L., et al.
Published: (2021)

mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines
by: Zhang, Biyan, et al.
Published: (2022)

Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
by: CS, L., et al.
Published: (2022)

Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study
by: Gu, Yue, et al.
Published: (2023)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?
by: Lam, Winnie Wing-Chuen, et al.
Published: (2023)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
by: Goh, YS, et al.
Published: (2021)

Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
by: Lee, C.Y.-P., et al.
Published: (2021)

Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
by: Seow, Justine Jia Wen, et al.
Published: (2022)

Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
by: Ong, Eugenia Z., et al.
Published: (2022)

Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019
by: Ong, S.W.X., et al.
Published: (2021)

Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies
by: Lau, C. S., et al.
Published: (2022)

SARS-CoV-2 Omicron variant shedding during respiratory activities
by: Sen Tan, Kai, et al.
Published: (2023)

Importations of COVID-19 into African countries and risk of onward spread
by: Sun, H., et al.
Published: (2021)

Insights into the first seven-months of COVID-19 pandemic in Bangladesh: lessons learned from a high-risk country
by: Siam, Md. Hasanul Banna, et al.
Published: (2022)

Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
by: Haddad, N, et al.
Published: (2021)

Positive anti-SSA/Ro antibody in a woman with SARS-CoV-2 infection using immunophenotyping: A case report
by: Huang, P.-I., et al.
Published: (2021)

Neurology of COVID-19 in Singapore
by: Koh, JS, et al.
Published: (2020)

Rapid production of clinical-grade SARS-CoV-2 specific T cells.
by: Leung, Wing, et al.
Published: (2022)

Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study
by: Fan, Bingwen Eugene, et al.
Published: (2021)